Pediatric Kidney Transplantation, Ureteroneocystostomy Techniques
TUIKIT
The Optimal Method for Ureter Implantation in Pediatric Kidney Transplantation
1 other identifier
observational
398
1 country
1
Brief Summary
In this study the researchers want to retrospectively compare non-refluxing ureteroneocystostomy (UNC techniques to reflux UNC techniques in paediatric kidney recipients with regard to urinary tract infections and uteral obstruction.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 25, 2022
CompletedFirst Posted
Study publicly available on registry
May 31, 2022
CompletedStudy Start
First participant enrolled
June 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2024
CompletedDecember 5, 2023
December 1, 2023
1.1 years
May 25, 2022
December 3, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Urinary tract infections
Number of urinary tract infections (with fever)
25 year
Ureteral obstruction
Number of ureteral obstruction needing intervention
25 year
Secondary Outcomes (1)
Graft survival
25 years
Study Arms (2)
Radboudumc recipients
NTX performed with a refluxing technique
Winsconsin recipients
NTX performed with a non-refluxing technique
Interventions
In general, UNC techniques can be divided in being either intravesical or extravesical and refluxing or non-refluxing
Eligibility Criteria
Pediatric kidney recipients that were transplanted between 1994-2018 in either Radboudumc or Winconsin University
You may qualify if:
- received kidney graft in the participating centres at an age \<19
- received kidney graft between 1994-2018
- follow-up data of at least 1 year
You may not qualify if:
- \- Loss of follow up \< 1 year
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Radboud University Medical Center
Nijmegen, 6500HB, Netherlands
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Liesbeth Lamers, MD
Radboud University Medical Center
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 25, 2022
First Posted
May 31, 2022
Study Start
June 1, 2023
Primary Completion
July 1, 2024
Study Completion
November 1, 2024
Last Updated
December 5, 2023
Record last verified: 2023-12
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, CSR
- Time Frame
- 25 year
- Access Criteria
- well written request
On request